Clinical Trial of Keytruda and Lynparza Combination Fails to Meet Primary Endpoint for Treatment of Metastatic Nonsquamous Non-Small Cell Lung Cancer

1 min read

Despite not having a positive outcome, safety profiles for Keytruda and Lynparza were consistent with previous findings.

You May Also Like

More From Author

+ There are no comments

Add yours